| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |